Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
COMPOSITIONS FOR TREATING IMBALANCES OF THE GUT MICROBIOTA
Publication Date 14.12.2023
"The tomato extract can be used improve resistance to infection in the gut, reduce inflammation in the gut, treat or minimise inflammatory Bowel Disease or treat or minimise irritable bowel syndrome. The extracts may also be used to treat conditions associated with an imbalance of the gut microbiota such as anxiety, depression, Type II diabetes, non-alcoholic fatty liver disease, obesity or cognitive dysfunction."
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023237878&_cid=P12-LQ6875-04787-1
Https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023237878&_cid=P12-LQ68ZU-24723-1
The health benefit conferred by WSTE may be one that directly impacts on the digestive system. For instance, WSTE may benefit a subject in at least one of the following ways:
(A) improving digestion;
(B) improving resistance to infection in the gut;
(C) reducing inflammation in the gut;
(D)treating or minimising inflammatory Bowel Disease (IBD); or
(E) treating or minimising irritable bowel syndrome (IBS).
Alternatively, the health benefit conferred by WSTE may be to address conditions whose pathology is caused or aggravated by compounds released by the gut microbiota into the bloodstream and whereby WSTE modulates plasma levels of such compounds by modulating the gut microbiota. For instance, WSTE also benefits a subject by:
(A) treating or preventing anxiety and/or depression;
(B) treating or preventing Type II diabetes;
(C) treating or preventing non-alcoholic fatty liver disease;
(D) Treating or preventing obesity;
(E) preventing or reducing inflammaging (or inflamm-aging);
(F) Immune disorders; and
(G) Improving or maintaining cognitive function and brain health.
Awesome!! Good find Gix.
For some mysterious reason the name of our professor is not there
Inventors
DUSS, Ruedi
STEINERT, Robert
REHMAN, Ateequr
The important bit is where it says.....
Applicants
PROVEXIS NATURAL PRODUCTS LIMITED
This must surely draw the attention of the Globals who are already interested and others who were maybe on the sidelines about the potential of ff.
Obviously these were the extra benefits that IF talked about last year . .................(A) treating or preventing anxiety and/or depression;
(B) treating or preventing Type II diabetes;
(C) treating or preventing non-alcoholic fatty liver disease;
(D) Treating or preventing obesity;
(E) preventing or reducing inflammaging (or inflamm-aging);
(F) Immune disorders; and
(G) Improving or maintaining cognitive function and brain health.
Of course, being invested in Provexis for 14 years with a current SP of less than 1p under the current lacklustre CEO, is not conducive to good mental health. This is never going anywhere. Whatever happened to Blue Hat or whatever that was called? Absolute dog of a share in the wrong hands but excellent product.
Why would you care CB? Seems like an odd obsession.
Its difficult to take someones opinion on the company serious when they cant even take the time to read an RNS that would answer their question.
Email address for Sircoheart comes back undelivered:Anyone else tried contacting them?
Hi Gixer, just a bitter man IMO. Best he concentrates on the other company he has shares with.
Kievsky. If you're happy and contented with 14 wasted years under Moon and Ford and relaxed about a SP of less than 1p, the inability to make a profit and STILL no meaningful progress, then I assume you are deluded.
Can you honestly think of an easier job on the AIM, than being CEO of Provexis? Made even easier by docile shareholders like you.
CB
the previous CEO used PXS to get hold of SIS. We should start to have sight of really how ‘good’ the deal he did was in a couple of weeks.
IF has kept things steady (fund raises, deal with ex employee Felix -wonder how he got on with former CEO) whilst counting down to givin the bird to DSM.
Yep SP is carp, but we all know that, and we know you know that
WS
WS